BRIEF published on 07/24/2025 at 14:16, 1 year ago FUTRUE GmbH Proposes Squeeze-Out for PharmaSGP Minority Shareholders Shareholders Compensation Squeeze-out PharmaSGP Futrue GmbH
PRESS RELEASE published on 07/24/2025 at 14:11, 1 year ago EQS-Adhoc: FUTRUE GmbH submits request to implement squeeze-out of minority shareholders of PharmaSGP Holding SE FUTRUE GmbH requests squeeze-out of minority shareholders by PharmaSGP Holding SE as it holds over 95% shares. Valuation ongoing for cash compensation determination Squeeze-out Minority Shareholders Cash Compensation PharmaSGP Holding SE Futrue GmbH
BRIEF published on 07/18/2025 at 12:02, 1 year ago PharmaSGP Holding SE Announces Delisting Offer by FUTRUE GmbH Shareholders Healthcare Products Delisting Offer PharmaSGP Futrue GmbH
PRESS RELEASE published on 07/18/2025 at 11:57, 1 year ago PharmaSGP Holding SE: Acceptance period for FUTRUE GmbH’s public delisting tender offer underway PharmaSGP Holding SE announces FUTRUE GmbH's public delisting tender offer acceptance period. Shareholders can tender shares for €28.00 cash consideration until August 11, 2025 Shareholders Tender Offer Delisting Cash Consideration PharmaSGP Holding SE
BRIEF published on 07/11/2025 at 08:06, 1 year ago PharmaSGP Holding SE Revises 2025 Revenue Forecast Adjusted EBITDA Revenue Adjustment PharmaSGP 2025 Forecast Geopolitical Uncertainty
PRESS RELEASE published on 07/11/2025 at 08:01, 1 year ago EQS-Adhoc: PharmaSGP Holding SE adjusts its revenues forecast for the full year 2025 PharmaSGP Holding SE adjusts full year 2025 revenue forecast due to current data evaluation. Adjusted forecast now €132.0-138.0 million. EBITDA expectation maintained EBITDA Revenue Forecast PharmaSGP Holding SE Adjusted Forecast 2025 Fiscal Year
BRIEF published on 06/26/2025 at 12:44, 1 year 1 month ago PharmaSGP Holding SE Holds Annual General Meeting 2025 Financial Results Dividend Policy Annual Meeting PharmaSGP 2025 Forecast
PRESS RELEASE published on 06/26/2025 at 12:39, 1 year 1 month ago PharmaSGP Holding SE holds 2025 Annual General Meeting PharmaSGP Holding SE reports on 2025 Annual General Meeting, with 91.12% share capital represented, €0.05 dividend per share approved, and confirmation of 2025 fiscal year forecast Annual General Meeting Dividend Forecast PharmaSGP Holding SE OTC Pharmaceuticals
BRIEF published on 06/18/2025 at 17:34, 1 year 1 month ago PharmaSGP SE to Redeem Shares Amid Upcoming Delisting Treasury Shares Delisting Squeeze-out Share Redemption PharmaSGP
PRESS RELEASE published on 06/18/2025 at 17:29, 1 year 1 month ago PharmaSGP SE plans to redeem own shares – conditions for squeeze-out under conversion law are met PharmaSGP SE plans to redeem treasury shares to optimize use of new authorization, leading to a squeeze-out possibility due to increased ownership percentage Share Buyback Treasury Shares Squeeze-out PharmaSGP Conversion Law
Published on 08/04/2026 at 09:10, 40 minutes ago HM Exploration Drills 18.45 Metres of 1.14% Cu, 2.42 % Zn, 16.74 g/t Ag and 0.32 g/t Au in Upper Lens; 5.42m of 1.99% Cu, 1.66% Zn, 15.39g/t Ag and 0.8g/t Au in Lower lens at Lewis Pilley's
Published on 08/04/2026 at 09:05, 45 minutes ago BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline
Published on 08/03/2026 at 23:00, 10 hours 50 minutes ago Viemed Healthcare Announces Second Quarter 2026 Financial Results
Published on 08/01/2026 at 01:20, 3 days 8 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 3 days 8 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/04/2026 at 08:30, 1 hour 20 minutes ago International Personal Finance plc - Suspension
Published on 08/04/2026 at 08:30, 1 hour 20 minutes ago Mutares grows and generates Group revenues of EUR 3.4 billion in the first half of 2026 – further exit activities expected in the second half, guidance for fiscal year 2026 confirmed
Published on 08/04/2026 at 08:15, 1 hour 35 minutes ago Covivio - Conditions of availability of the 2026 Half-year report
Published on 08/03/2026 at 18:45, 15 hours 5 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 17:45, 16 hours 5 minutes ago Monthly disclosure of the total number of shares and voting rights - July 2026
